Blue Water Vaccines, Inc. Profile
Industry
BiotechnologySector
HealthcareNumber of Employees
12Blue Water Vaccines's Business Model
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
About Blue Water Vaccines
Website: https://www.bluewatervaccines.com
CEO (Chief Executive Officer): Dr. Neil J. Campbell MA, MBA
IPO date: 2022-02-18
Contact
Country: US
Address: 201 East Fifth Street
City: Cincinnati
State: OH
Phone: 513 620 4101
Zip Code: 45202
Other
CIK: 0001782107
ISIN: US09610B1089
CUSIP: 09610B108
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
